Experimental Design Gate
Define before optimizing
Write the biological question, experimental unit, primary endpoint, minimum meaningful effect, intervention/contrast, and falsifiable hypothesis. Distinguish biological from technical replication.
Audit
Check:
- material and model-system relevance;
- controls, randomization, blocking, blinding, and batch balance;
- nesting, repeated measures, pairing, and independence;
- sample-size justification using a defensible effect range or simulation;
- measurement timing, dynamic range, failure thresholds, and missing-data handling;
- whether the planned statistic estimates the biological quantity of interest.
Decision
Return one of:
Go: the design can test the claim;
Revise-and-Go: named changes are required before proceeding;
No-Go: the current materials or design cannot identify the claimed effect.
Do not rescue a No-Go by adding omics, enrichment, machine learning, or more figures. State the smallest change that would alter the decision.
Deliverable
Provide a design map, control table, sample-size assumptions, analysis skeleton, failure criteria, and records to preserve. Separate confirmatory endpoints from exploratory measurements.
1---2name: experimental-design-gate3description: Audit whether biological materials, sampling, controls, replication, and measurements can answer a proposed question before experiments or analysis. Use for study planning and Go/No-Go decisions.4metadata:5 source: https://skillmd.com/skills/minimax-ai/experimental-design-gate6---78# Experimental Design Gate910## Define before optimizing1112Write the biological question, experimental unit, primary endpoint, minimum meaningful effect, intervention/contrast, and falsifiable hypothesis. Distinguish biological from technical replication.1314## Audit1516Check:1718- material and model-system relevance;19- controls, randomization, blocking, blinding, and batch balance;20- nesting, repeated measures, pairing, and independence;21- sample-size justification using a defensible effect range or simulation;22- measurement timing, dynamic range, failure thresholds, and missing-data handling;23- whether the planned statistic estimates the biological quantity of interest.2425## Decision2627Return one of:2829- `Go`: the design can test the claim;30- `Revise-and-Go`: named changes are required before proceeding;31- `No-Go`: the current materials or design cannot identify the claimed effect.3233Do not rescue a No-Go by adding omics, enrichment, machine learning, or more figures. State the smallest change that would alter the decision.3435## Deliverable3637Provide a design map, control table, sample-size assumptions, analysis skeleton, failure criteria, and records to preserve. Separate confirmatory endpoints from exploratory measurements.